Targeted therapies for transthyretin amyloid cardiomyopathy (ATTR-CM) were associated with significant reductions in ...
Results showed the combination reduced the risk of death by 24% compared with chemotherapy alone, extending median OS to 18.2 ...
News-Medical.Net on MSN
Distinct gut toxicity patterns emerge with targeted cancer treatments
A new paper was published in Volume 13 of Oncoscience on February 6, 2026, titled "Gastrointestinal toxicity of targeted cancer therapies in the United States: Clinicopathologic patterns, FDA safety ...
Everyday Health on MSN
Novel targeted therapies for IgAN: What you need to know
Explore novel therapies for IgA nephropathy that target inflammation and antibody production. Learn how these advancements ...
“This review synthesizes current evidence to inform clinical decision-making and outlines future directions for durable, personalized lymphoma care" In this article by Bishal Tiwari, Roshan Afshan and ...
The Claudin18.2 targeted therapy market offers significant opportunities in treating advanced cancers such as gastric and pancreatic. With one approved therapy and over 70 in clinical trials, ...
Survivorship Care for People Affected by Advanced or Metastatic Cancer: Building on the Recent Multinational Association of Supportive Care in Cancer-ASCO Standards and Practice Recommendations The ...
In patients with Ph-positive disease, TKIs should be used continuously, which may lead to toxicities. This must be considered during therapy selection. The optimal duration of TKI maintenance is not ...
Targeted therapies are medicines to treat cancer. They work differently than standard chemotherapy. Instead of killing all fast-growing cells or keeping them from dividing, targeted therapies work ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results